Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO) : a Randomized Control Trial

NCT05216757 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT05216757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05216757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Iguratimod in Patients With Hand Osteoarthritis (ESIGO) : a Randomized Control Trial
Lead sponsor
Peking University People's Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 31, 2022
Completion date
December 31, 2024
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hand osteoarthritis, inflammatory arthritis